SAN DIEGO — High cure rates can be achieved with fosfomycin in patients with chronic prostatitis — many of whom are resistant to the current first-line treatment of fluoroquinolones — according to ...

Escherichia coli is the most common cause of bacterial prostatitis. Findings from a small study suggest it could be an effective, safe, and attractive alternative to fluoroquinolones, bacterial ...

Fosfomycin is effective against Gram-positive and Gram-negative bacteria, including drug-resistant strains, and is economically viable for treating uncomplicated UTIs. A meta-analysis of 22 studies ...